Source: ANSA

The III Section of the Council of State accepted, as a precautionary measure, the appeal of a group of general practitioners and suspended AIFA’s note of 22 July last which prohibited off-label prescription (i.e. for a use not provided for in the leaflet) hydroxychloroquine for the fight against Covid.

“The continuing uncertainty about the therapeutic efficacy of hydroxychloroquine, admitted by the AIFA itself to justify further evaluation in randomized clinical trials – reads the ordinance – is not sufficient legal reason to justify the unreasonable suspension of its use on the national territory “. 

“A right opportunity for treatment has been returned to the Italians, taking into account the evidence of the territories. We are really satisfied”. The lawyer Erich Grimaldi, who promoted and supported the petition of a group of doctors against the suspension of the use of hydroxychloroquine in home care protocols for Covid, comments on today’s decision of the State Council.

“From today, the prescription of the drug is allowed – continues Grimaldi – under the precise responsibility of the doctor and under his strict control, to patients suffering from Covid in the initial phase of the disease. This means respecting the medical profession, exercised in science and conscience, as we have always supported “.

Since March, the lawyer Grimaldi has collected the experience of doctors from various Italian regions who had successfully used the drug. Among these the professor Luigi Cavanna from Piacenza, the doctor Paola Varese of Ovada (Alessandr9a), the doctor Luigi Garavelli of Novara, the doctor Riccardo Szumski of Treviso and the doctor Andrea Mangiagalli of Milan.

Related: Coronavirus and hydroxychloroquine. A cure that works, but that is not authorized …

A massive hydroxychloroquine meta-analysis (156 studies) has just been updated (version 28!).It says that HCQ works beyond all statistical doubt.

‘Only a one in 17 billion chance hydroxychloroquine doesn’t work’: medical professor

A Guide to Home-Based COVID Treatment -A Step-By-Step Doctors’ Plan That Could Save Your Life

Peer-reviewed hydroxychloroquine study finds 84% fewer hospitalizations among early treated outpatients

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »